Management of Neonatal Hyperglycaemia in Sweden—A Survey Study
Acta Paediatrica · 2025
DOI: 10.1111/apa.17583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, 2025. Verfasst von Ludvig Henriksson Frithiof und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Hyperglycemia, Infant, Premature, Diseases, Practice Patterns, Physicians'. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Region Västerbotten, Umeå Universitet, Svenska Läkaresällskapet.
Abstract (Originalsprache)
Aim
Neonatal hyperglycaemia is associated with a multitude of adverse outcomes, including mortality and impaired neurological development. The aim of this study was to characterise the current management of neonatal hyperglycaemia in Swedish neonatal units.
Methods
A digital survey was sent to 27 Swedish neonatal units providing care to preterm infants born before 32 completed gestational weeks.
Results
Sixty‐eight responses were collected from 21 different units. Thirty‐two percent (22/68) of clinicians reported having a local treatment guideline for neonatal hyperglycaemia. Hyperglycaemia was defined as a glucose concentration above a value in the range of 8.0–10.0 mmol/L by 62.5% of clinicians, while 16.7% and 21.8% used a definition between 10.1 and 12.0 mmol/L and > 12 mmol/L, respectively. Intravenous glucose reduction was initiated at higher glucose concentrations by clinicians working at university hospital units ( p = 0.006). Glucose concentration threshold for initiation of insulin treatment varied between 8 and 30 mmol/L. Three clinicians (3/35 (8.5%)) reported having experienced problems with frequent hypoglycaemia during ongoing insulin treatment.
Conclusions
This study demonstrates extensive differences in clinical practice regarding neonatal hyperglycaemia both within and between neonatal units in Sweden. Randomised controlled trials are needed to provide evidence for clinical guidelines and to improve and standardise the care of these infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
ORCID-Profile: Ludvig Henriksson Frithiof, Itay Nilsson Zamir
Förderung
- Region Västerbotten
- Umeå Universitet
- Svenska Läkaresällskapet
Zitieren
APA
Frithiof, L. H., Domellöf, M., & Zamir, I. N. (2025). Management of Neonatal Hyperglycaemia in Sweden—A Survey Study. Acta Paediatrica. https://doi.org/10.1111/apa.17583
Vancouver
Frithiof LH, Domellöf M, Zamir IN. Management of Neonatal Hyperglycaemia in Sweden—A Survey Study. Acta Paediatrica. 2025. doi:10.1111/apa.17583
BibTeX
@article{Frithiof2025,
author = {Frithiof, Ludvig Henriksson and Domellöf, Magnus and Zamir, Itay Nilsson},
title = {Management of Neonatal Hyperglycaemia in Sweden—A Survey Study},
journal = {Acta Paediatrica},
year = {2025},
doi = {10.1111/apa.17583}
}
EUVIMED